Merkel cell carcinoma: A second primary tumor following treatment for non- Hodgkin's lymphoma

D. F. Moore; M. H. Huber; S. M. Lippman; F. B. Hagemeister

Merkel cell carcinoma: A second primary tumor following treatment for non- Hodgkin's lymphoma

D. F. Moore, M. H. Huber, S. M. Lippman, F. B. Hagemeister

Lymphoma-Myeloma

Research output: Contribution to journal › Article › peer-review

Abstract

SURVIVORS OF non-Hodgkin's lymphoma (NHL) are at increased risk of developing second primary malignancies long after completing treatment. Cutaneous neuroendocrine (Merkel cell) carcinoma is an unusual and aggressive malignancy not previously described as a second primary minor in patients with NHL. We report the occurrence of a Merkel cell carcinoma in a patient with a history of NHL and briefly discuss factors that may contribute to the development of second primary tumors.

Original language	English (US)
Pages (from-to)	175-177
Number of pages	3
Journal	Cancer Bulletin
Volume	47
Issue number	2
State	Published - 1995

ASJC Scopus subject areas

Cancer Research

Cite this

@article{97fc9e6661764a33bcaa2536c877c96c,

title = "Merkel cell carcinoma: A second primary tumor following treatment for non- Hodgkin's lymphoma",

abstract = "SURVIVORS OF non-Hodgkin's lymphoma (NHL) are at increased risk of developing second primary malignancies long after completing treatment. Cutaneous neuroendocrine (Merkel cell) carcinoma is an unusual and aggressive malignancy not previously described as a second primary minor in patients with NHL. We report the occurrence of a Merkel cell carcinoma in a patient with a history of NHL and briefly discuss factors that may contribute to the development of second primary tumors.",

author = "Moore, {D. F.} and Huber, {M. H.} and Lippman, {S. M.} and Hagemeister, {F. B.}",

year = "1995",

language = "English (US)",

volume = "47",

pages = "175--177",

journal = "Cancer Bulletin",

issn = "0740-820X",

publisher = "Medical Arts Publishing",

number = "2",

}

TY - JOUR

T1 - Merkel cell carcinoma

T2 - A second primary tumor following treatment for non- Hodgkin's lymphoma

AU - Moore, D. F.

AU - Huber, M. H.

AU - Lippman, S. M.

AU - Hagemeister, F. B.

PY - 1995

Y1 - 1995

N2 - SURVIVORS OF non-Hodgkin's lymphoma (NHL) are at increased risk of developing second primary malignancies long after completing treatment. Cutaneous neuroendocrine (Merkel cell) carcinoma is an unusual and aggressive malignancy not previously described as a second primary minor in patients with NHL. We report the occurrence of a Merkel cell carcinoma in a patient with a history of NHL and briefly discuss factors that may contribute to the development of second primary tumors.

AB - SURVIVORS OF non-Hodgkin's lymphoma (NHL) are at increased risk of developing second primary malignancies long after completing treatment. Cutaneous neuroendocrine (Merkel cell) carcinoma is an unusual and aggressive malignancy not previously described as a second primary minor in patients with NHL. We report the occurrence of a Merkel cell carcinoma in a patient with a history of NHL and briefly discuss factors that may contribute to the development of second primary tumors.

UR - http://www.scopus.com/inward/record.url?scp=0029055418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029055418&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029055418

SN - 0740-820X

VL - 47

SP - 175

EP - 177

JO - Cancer Bulletin

JF - Cancer Bulletin

IS - 2

ER -

Merkel cell carcinoma: A second primary tumor following treatment for non- Hodgkin's lymphoma

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this